Glycosaminoglycan-based Biomaterials For Growth Factor And Cytokine Delivery: Making The Right Choices
Daniel Hachim, Thomas E Whittaker, Hyemin Kim, Molly M Stevens
Published 2019 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
This paper references
Complexation and Sequestration of BMP-2 from an ECM Mimetic Hyaluronan Gel for Improved Bone Formation
Marta A. Kisiel (2013)
Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.
Andrea Zieris (2011)
Dermatan sulfate: new functions from an old glycosaminoglycan.
Janet M. Trowbridge (2002)
Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair.
Dilek Keskin (2005)
Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study.
Bernd Stadlinger (2005)
Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
Hiroko Habuchi (1992)
The structure of glycosaminoglycans and their interactions with proteins.
Neha S. Gandhi (2008)
Biohybrid networks of selectively desulfated glycosaminoglycans for tunable growth factor delivery.
Andrea Zieris (2014)
Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity
Kayo Masuko (2009)
Novel Surface Coatings Using Oxidized Glycosaminoglycans as Delivery Systems of Bone Morphogenetic Protein 2 (BMP-2) for Bone Regeneration.
Reema Anouz (2018)
Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds
Qi Tan (2011)
Injectable shear-thinning nanoengineered hydrogels for stem cell delivery.
Ashish Thakur (2016)
Roles of glycosaminoglycans as regulators of ligand/receptor complexes
Robert G. Smock (2018)
Application of hyaluronic acid as carriers in drug delivery
Gangliang Huang (2018)
A single injection of protein-loaded coacervate-gel significantly improves cardiac function post infarction.
Hassan K. Awada (2017)
A [polycation:heparin] complex releases growth factors with enhanced bioactivity.
Hunghao Chu (2011)
Chondroitin sulfate prevents platelet derived growth factor-mediated phosphorylation of PDGF-Rbeta in normal human fibroblasts severely impairing mitogenic responses.
Eleni Fthenou (2008)
Chondroitin Sulfate Inhibits the Nuclear Translocation of Nuclear Factor‐κB in Interleukin‐1β‐Stimulated Chondrocytes
Claudia Jomphe (2007)
ECM based injectable thermo-sensitive hydrogel on the recovery of injured cartilage induced by osteoarthritis
Yitong Li (2018)
The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization.
Inbar Freeman (2009)
Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor.
Jung Seok Lee (2007)
Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.
S F Penc (1999)
Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB.
Neil H Davies (2012)
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications
Bethanie I. Ayerst (2017)
Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.
D Clarke (1995)
Charge-tuning of glycosaminoglycan-based hydrogels to program cytokine sequestration.
Uwe Freudenberg (2019)
Heterogeneity of the Chondroitin Sulfate Portion of Phosphacan/6B4 Proteoglycan Regulates Its Binding Affinity for Pleiotrophin/Heparin Binding Growth-associated Molecule*
Nobuaki Maeda (2003)
Proteoglycans, glycosaminoglycans and sulfated polysaccharides from connective tissues.
Paulo A. S. Mourão (1991)
Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor.
Marta A. Princz (2012)
Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate
Shigeki Higashiyama (1993)
Novel 70-kDa Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains with a Unique Heterogenous Sulfation Pattern from Shark Skin, Which Exhibit Neuritogenic Activity and Binding Activities for Growth Factors and Neurotrophic Factors*
Chilkunda D. Nandini (2005)
Hydrolysis and Sulfation Pattern Effects on Release of Bioactive Bone Morphogenetic Protein-2 from Heparin-Based Microparticles.
Liane E Tellier (2015)
GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan sulfate proteoglycans.
Márcio Alvarez-Silva (1996)
Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions
Ruoyan Xu (2012)
Nano and Microparticles as Controlled Drug Delivery Devices
Ravi Kumar M.N.V. (2000)
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis
Hunghao Chu (2011)
Chondrogenic potential of injectable κ-carrageenan hydrogel with encapsulated adipose stem cells for cartilage tissue-engineering applications.
Elena Geta Popa (2015)
Glycosaminoglycan and Proteoglycan‐Based Biomaterials: Current Trends and Future Perspectives
Jelena Rnjak-Kovacina (2018)
Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications.
Yingkai Liang (2014)
A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.
Aaron Watkins James (2016)
Proteoglycans and Sulfated Glycosaminoglycans
Ulf Lindahl (2009)
Interaction of heparin with synthetic antithrombin III peptide analogues.
Jooeun Bae (1994)
StarPEG-Heparin Hydrogels to Protect and Sustainably Deliver IL-4.
Lucas Schirmer (2016)
Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
Katharine J Goodall (2014)
Photo-crosslinking hyaluronan-heparin hybrid hydrogels for BMP-2 sustained delivery
Tianqi He (2016)
Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice.
Giuseppe Maurizio Campo (2008)
Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation.
Danielle S W Benoit (2005)
Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1α) Binding to Heparin*
James W. Murphy (2007)
Biofunctionalization of ulvan scaffolds for bone tissue engineering.
Mamoni Dash (2014)
Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds.
Noah Ray Johnson (2015)
Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins.
Lijuan Zhang (2010)
VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase*
Christopher J. Robinson (2006)
Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells.
Silvana Prokoph (2012)
Immunological activity of chondroitin sulfate.
Toshihiko Toida (2006)
Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4).
Vera Hintze (2009)
Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.
Jillian E Tengood (2010)
Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin*
R. Jasuja (2004)
Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.
William C W Chen (2015)
Fucoidan: Structure and Bioactivity
Bo Li (2008)
Immunomodulation and cellular response to biomaterials: the overriding role of neutrophils in healing
Biaou O. Ode Boni (2019)
Heparan Sulfate Regulates VEGF165- and VEGF121-mediated Vascular Hyperpermeability*
Ding Xu (2010)
Applications of electrospinning/electrospraying in drug delivery
Azin Jahangiri (2016)
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB
Yolanda Parajó (2010)
From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods
Jan-Ytzen van der Meer (2017)
Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine*
Ali Amara (1999)
Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice
Nadine Lohmann (2017)
Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.
Danielle E. Soranno (2016)
Interactions between extracellular matrix and growth factors in wound healing.
Gregory Scott Schultz (2009)
Designing hydrogels for controlled drug delivery.
Jianyu Li (2016)
Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Oju Jeon (2006)
Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
Lorna D. Thompson (1994)
Chondroitin-6-sulfate attenuates inflammatory responses in murine macrophages via suppression of NF-κB nuclear translocation.
Guak-Kim Tan (2014)
Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration.
Yoon Jeong Park (2000)
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells
Richard A. Majack (1985)
The nonlinear viscoelasticity of hyaluronic acid and its role in joint lubrication.
Zhenhuan Zhang (2015)
Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines
Shuji Mizumoto (2012)
The anti-inflammatory effects of heparin and related compounds.
Edward Young (2008)
Modulation of macrophage phenotype and protein secretion via heparin-IL-4 functionalized supramolecular elastomers.
Valentina Bonito (2018)
Fucoidan modulates the effect of transforming growth factor (TGF)-beta1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair.
Ronan O’Leary (2004)
Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
M Ishihara (1994)
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
Erik Forsberg (1999)
FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation.
Katherine A. Radek (2009)
In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading.
Pauline B van Wachem (2001)
Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds.
Uwe Freudenberg (2015)
Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model
Junming Chen (2012)
Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing.
Noah Ray Johnson (2013)
Characterization of a chondroitin sulfate hydrogel for nerve root regeneration.
Aaron W. Conovaloff (2011)
Coacervate Delivery of Growth Factors Combined with a Degradable Hydrogel Preserves Heart Function after Myocardial Infarction
Noah Ray Johnson (2015)
S5.13 Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor
Marco Maccarana (2005)
Basic fibroblast growth factor released from fucoidan-modified chitosan/alginate scaffolds for promoting fibroblasts migration
Huang-Yu Zeng (2018)
Adaptive release of heparin from anticoagulant hydrogels triggered by different blood coagulation factors.
Manfred F Maitz (2017)
Long-term local PDGF delivery using porous microspheres modified with heparin for tendon healing of rotator cuff tendinitis in a rabbit model.
Seok Ho Kang (2019)
Elucidating glycosaminoglycan–protein–protein interactions using carbohydrate microarray and computational approaches
Claude J. Rogers (2011)
Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.
Hassan K. Awada (2015)
Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration
Hee Seok Yang (2012)
Marine Polysaccharides: A Source of Bioactive Molecules for Cell Therapy and Tissue Engineering
Karim Senni (2011)
Heparin and heparan sulfate bind interleukin-10 and modulate its activity.
Shahram Salek-Ardakani (2000)
Importance of specific amino acids in protein binding sites for heparin and heparan sulfate.
E E Caldwell (1996)
The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics
Ariana A. Vasconcelos (2017)
HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans
Ryo Iwamoto (2010)
Chondroitin Sulfate Glycosaminoglycan Hydrogels Create Endogenous Niches for Neural Stem Cells.
Lohitash Karumbaiah (2015)
Viscoelastic Properties of Hyaluronan in Physiological Conditions
Mary K. Cowman (2015)
Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery.
Jeremy J. Lim (2011)
A new biocompatible delivery scaffold containing heparin and bone morphogenetic protein 2
Suphannee Thanyaphoo (2016)
Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites.
Saloua Najjam (1998)
Synergistic Effects of SDF-1α and BMP-2 Delivery from Proteolytically Degradable Hyaluronic Acid Hydrogels for Bone Repair.
Julianne L. Holloway (2015)
Heparan Sulfate Proteoglycans Retain Noggin at the Cell Surface
Stephenie Paine-Saunders (2002)
Identification and characterization of a glycosaminoglycan binding site on interleukin-10 via molecular simulation methods.
Jan-Philip Gehrcke (2015)
Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Yan Bai (2018)
Prediction of heparin binding sites in bone morphogenetic proteins (BMPs).
Neha S. Gandhi (2012)
Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2.
Hee Seok Yang (2010)
Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2*
Johan Kreuger (2001)
Human interleukin 4 is a glycosaminoglycan-binding protein.
Hugues Lortat-Jacob (1997)
Characterization of the Heparin-Binding Properties of IL-61
Rosemary S. Mummery (2000)
Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2.
Marian H. Hettiaratchi (2014)
Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins.
Ronald E. Hileman (1998)
The effect of delivering the chemokine SDF-1α in a matrix-bound manner on myogenesis.
Fabien Dalonneau (2014)
Structural and Sequence Motifs in Dermatan Sulfate for Promoting Fibroblast Growth Factor-2 (FGF-2) and FGF-7 Activity*
Kristen R. Taylor (2005)
Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny.
Swetlana Sirko (2010)
Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
Bin Wang (2015)
Extracellular Matrix and Cytokines: A Functional Unit
Elke Schönherr (2000)
Structural features in heparin that interact with VEGF165 and modulate its biological activity.
Katsuhiro Ono (1999)
Desulfation of Sulfated Carbohydrates
Ryo Takano (2002)
Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization.
Ronald Ian William Osmond (2002)
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Joshua Brown (2012)
Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin.
Alina D Zamfir (2003)
Structure and function in extracellular matrices depend on interactions between anionic glycosaminoglycans.
John E. S. Scott (2001)
Heparin-Binding-Affinity-Based Delivery Systems Releasing Nerve Growth Factor Enhance Sciatic Nerve Regeneration
Matthew D Wood (2010)
Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.
Lynne M. Webb (1993)
In situ formation of poly(vinyl alcohol)–heparin hydrogels for mild encapsulation and prolonged release of basic fibroblast growth factor and vascular endothelial growth factor
Justine J. Roberts (2016)
Developmental cell biology: Heparan sulphate proteoglycans: the sweet side of development
Udo Häcker (2005)
Functions of heparan sulfate proteoglycans in cell signaling during development
Xinhua Lin (2004)
Development of affinity-based delivery of NGF from a chondroitin sulfate biomaterial
Karen Chao Butterfield (2011)
Monocyte Cell Surface Glycosaminoglycans Positively Modulate IL-4-Induced Differentiation toward Dendritic Cells1
Els den Dekker (2008)
Heparin is essential for the storage of specific granule proteases in mast cells
Donald E. Humphries (1999)
Heparinized collagen sutures for sustained delivery of PDGF-BB: Delivery profile and effects on tendon-derived cells In-Vitro.
Mousa Younesi (2016)
Chondroitin sulfate-based nanocarriers for drug/gene delivery.
Lili Zhao (2015)
Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans
Gregory M. Miller (2015)
Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.
Oju Jeon (2011)
Chondroitin Sulfate “Wobble Motifs” Modulate Maintenance and Differentiation of Neural Stem Cells and Their Progeny*
Anurag Purushothaman (2011)
In situ-forming, cell-instructive hydrogels based on glycosaminoglycans with varied sulfation patterns.
Passant Atallah (2018)
The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1.
Steven M. Rickard (2003)
Electrospun scaffolds functionalized with heparin and vascular endothelial growth factor increase the proliferation of endothelial progenitor cells.
D I Braghirolli (2017)
Chondroitin/dermatan sulfate in the central nervous system.
Kazuyuki Sugahara (2007)
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides.
Wenjing Zhao (2012)
Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays.
Eric L Shipp (2007)
A controlled release system for simultaneous delivery of three human perivascular stem cell-derived factors for tissue repair and regeneration.
Nurlan Mansurov (2018)
Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold
Lei Chen (2010)
Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.
Tobias Miller (2014)
Sulfation patterns of glycosaminoglycans encode molecular recognition and activity
Cristal I Gama (2006)
Evaluation of hyaluronan as a vehicle for peptide growth factors
Per T. Prisell (1992)
Anti-inflammatory activity of chondroitin sulfate.
Francesca Ronca (1998)
Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.
Uwe Freudenberg (2016)
Specific Molecular Interactions of Oversulfated Chondroitin Sulfate E with Various Heparin-binding Growth Factors
Sarama Sathyaseelan Deepa (2002)
Controlled Release of Vascular Endothelial Growth Factor from Heparin-Functionalized Gelatin Type A and Albumin Hydrogels
Christiane Claaßen (2017)
The Effect of Heparin-VEGF Multilayer on the Biocompatibility of Decellularized Aortic Valve with Platelet and Endothelial Progenitor Cells
Xiaofeng Ye (2013)
Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha.
Elisabeth Mbemba (2000)
Neuronal Cell Adhesion, Mediated by the Heparin-binding Neuroregulatory Factor Midkine, Is Specifically Inhibited by Chondroitin Sulfate E
C Ueoka (2000)
Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ
Deokbum Park (2012)
Keratan sulfate: an up-to-date review.
Vitor H Pomin (2015)
Dermatan Sulfate Released after Injury Is a Potent Promoter of Fibroblast Growth Factor-2 Function*
S F Penc (1998)
Glycosaminoglycans from marine sources as therapeutic agents.
Jesús Valcarcel (2017)
The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit
Pascale Garnier (2018)
Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix.
Richard Lipscombe (1998)
Heparin derivatives prepared by modification of the uronic acid carboxyl groups
Isidore Danishefsky (1972)
Swelling pressures of proteoglycans at the concentrations found in cartilaginous tissues.
Jill P. G. Urban (1979)
Preparation, structure and BMP-2 controlled release of heparin-conjugated hyaluronan microgels
Jianhao Zhao (2011)
Encapsulation of adipose-derived stem cells and transforming growth factor-β1 in carrageenan-based hydrogels for cartilage tissue engineering
Pedro Rocha (2011)
Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation.
Tatsuya Miyazaki (2008)
Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration.
Daniel Hachim (2017)
N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.
Mabel L. Purkerson (1988)
Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing
Yuji Shirakata (2005)
Effects of PDGF-BB delivery from heparinized collagen sutures on the healing of lacerated chicken flexor tendon in vivo.
Mousa Younesi (2017)
The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release
Robin Neely Prince (2010)
Dual crosslinked chondroitin sulfate injectable hydrogel formed via continuous Diels-Alder (DA) click chemistry for bone repair.
Xiao Bai (2017)
Sulfated polysaccharide-based scaffolds for orthopaedic tissue engineering.
Jeremy Nicolas Dinoro (2019)
Heparan Sulfate Acts as a Bone Morphogenetic Protein Coreceptor by Facilitating Ligand-induced Receptor Hetero-oligomerization
Wan-Jong Kuo (2010)
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
G S Kuschert (1999)
Adipose-derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model.
Jiabing Fan (2014)
Keratan sulfate suppresses cartilage damage and ameliorates inflammation in an experimental mice arthritis model.
Masatoshi Hayashi (2010)
Regenerative potential of glycosaminoglycans for skin and bone
Juliane Salbach (2011)
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery
Suniti Misra (2015)
Chemistry and biology of heparin and heparan sulfate
Hari G. Garg (2005)
In vivo vascularization of MSC-loaded porous hydroxyapatite constructs coated with VEGF-functionalized collagen/heparin multilayers
Kai Jin (2016)
Enhanced flexor tendon healing through controlled delivery of PDGF-BB.
Stavros Thomopoulos (2009)
Hyaluronan/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor.
Stephan Thoenes (2019)
Chondroitin Sulfate Glycosaminoglycan Scaffolds for Cell and Recombinant Protein‐Based Bone Regeneration
Seth Andrews (2019)
Distinct release strategies are required to modulate macrophage phenotype in young versus aged animals.
Daniel Hachim (2019)
Is Heparin Effective for the Controlled Delivery of High-Dose Bone Morphogenetic Protein-2?
Ri Youn Kim (2016)
Enhanced in vivo retention of low dose BMP-2 via heparin microparticle delivery does not accelerate bone healing in a critically sized femoral defect.
Marian H. Hettiaratchi (2017)
Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the neuroprotective effects of proteins after spinal injury
He-Lin Xu (2018)
Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies
Yu Wang (2019)
Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2
Gerjon Hannink (2012)
Bio-responsive polymer hydrogels homeostatically regulate blood coagulation
Manfred F Maitz (2013)
This paper is referenced by
Recent Progress on Cellulose-Based Ionic Compounds for Biomaterials.
Yang Yang (2020)
Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines
Xiang-yan Chen (2020)